I'm sorry. I thought I highlighted that the objections to the Australian patent, which was the narrative of the article and is the least important patent, were based on objections from the EPO. It appears through the communications with the EPO these objections have been overcome and there is high probability for intention to grant the patent. Also, the US patent did receive a Non Final Rejection which was also overcome.
Is this not focussing on the patents? Patents are important but they need to work and they need to be commercial. So focus focus on the endgame or get a job at the AFR if you have a certificate in finance.
- Forums
- ASX - By Stock
- Patents Update
AXE
archer materials limited
Add to My Watchlist
0.00%
!
23.0¢

I'm sorry. I thought I highlighted that the objections to the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.61M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $89.25K | 387.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 56023 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 0.230 |
8 | 182195 | 0.225 |
11 | 234057 | 0.220 |
7 | 58193 | 0.215 |
8 | 164657 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 4141 | 1 |
0.240 | 101099 | 4 |
0.245 | 7000 | 1 |
0.250 | 76000 | 3 |
0.255 | 129000 | 3 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online